NR3C1 and B-cell non-Hodgkin lymphoma: It has been previously shown that a combination of a different EZH2 inhibitor, EPZ-6438, was synergistic with glucocorticoid receptor agonists such as prednisolone and dexamethasone in B cell lymphoma [34].